Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 956823, 9 pages
http://dx.doi.org/10.1155/2010/956823
Research Article

Proteomic Analysis of Pichindé virus Infection Identifies Differential Expression of Prothymosin-

1Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA
3Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555-0609, USA
4Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA
5Bio-Rad Laboratories, 6000 James Watson Drive, Hercules, CA 94547, USA
6Bioinformatics Program, University of Texas Medical Branch, Galveston, TX 77555-0609, USA
7Centers for Proteomics and Systems Biology, Brown Institute for Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA

Received 25 September 2009; Accepted 4 March 2010

Academic Editor: Shahid Jameel

Copyright © 2010 Gavin C. Bowick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Cummins, “Arenaviral haemorrhagic fevers,” Blood Reviews, vol. 5, no. 3, pp. 129–137, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. I. S. Lukashevich, R. Maryankova, A. S. Vladyko et al., “Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-a gene expression,” Journal of Medical Virology, vol. 59, no. 4, pp. 552–560, 1999. View at Google Scholar · View at Scopus
  3. S. M. Fennewald, J. F. Aronson, L. Zhang, and N. K. Herzog, “Alterations in NF-κ B and RBP-J κ by arenavirus infection of macrophages in vitro and in vivo,” Journal of Virology, vol. 76, no. 3, pp. 1154–1162, 2002. View at Google Scholar
  4. G. C. Bowick, S. M. Fennewald, B. L. Elsom et al., “Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections,” Journal of Virology, vol. 80, no. 20, pp. 10248–10252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. C. Bowick, S. M. Fennewald, E. P. Scott et al., “Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics,” Journal of Virology, vol. 81, no. 4, pp. 1923–1933, 2007. View at Google Scholar
  6. G. C. Bowick, H. M. Spratt, A. E. Hogg et al., “Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection,” Journal of Virology, vol. 83, no. 2, pp. 687–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. McCormick, I. J. King, P. A. Webb et al., “Lassa fever: effective therapy with ribavirin,” The New England Journal of Medicine, vol. 314, no. 1, pp. 20–26, 1986. View at Google Scholar
  8. K. M. Johnson, J. B. McCormick, P. A. Webb, E. S. Smith, L. H. Elliott, and I. J. King, “Clinical virology of Lassa fever in hospitalized patients,” Journal of Infectious Diseases, vol. 155, no. 3, pp. 456–464, 1987. View at Google Scholar · View at Scopus
  9. H. Wang, X. Yang, G. C. Bowick et al., “Identification of proteins bound to a thioaptamer probe on a proteomics array,” Biochemical and Biophysical Research Communications, vol. 347, no. 3, pp. 586–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Lan, L. M. Schelde, J. Wang, N. Kumar, H. Ly, and Y. Liang, “Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers,” Journal of Virology, vol. 83, no. 13, pp. 6357–6362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lan, L. McLay, J. Aronson, H. Ly, and Y. Liang, “Genome comparison of virulent and avirulent strains of the Pichinde arenavirus,” Archives of Virology, vol. 153, no. 7, pp. 1241–1250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. F. Aronson, N. K. Herzog, and T. R. Jerrells, “Pathological and virological features of arenavirus disease in guinea-pigs—comparison of 2 pichinde virus-strains,” American Journal of Pathology, vol. 145, no. 1, pp. 228–235, 1994. View at Google Scholar
  13. S. Baize, J. Kaplon, C. Faure, D. Pannetier, M.-C. Georges-Courbot, and V. Deubel, “Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells,” Journal of Immunology, vol. 172, no. 5, pp. 2861–2869, 2004. View at Google Scholar · View at Scopus
  14. R. B. Dyer and N. K. Herzog, “Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line,” BioTechniques, vol. 19, no. 2, pp. 192–195, 1995. View at Google Scholar
  15. J. D. Storey, J. Y. Dai, and J. T. Leek, “The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments,” Biostatistics, vol. 8, no. 2, pp. 414–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Storey, W. Xiao, J. T. Leek, R. G. Tompkins, and R. W. Davis, “Significance analysis of time course microarray experiments,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 36, pp. 12837–12842, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society Series B, vol. 57, pp. 289–300, 1995. View at Google Scholar
  18. J. D. Storey and R. Tibshirani, “Statistical significance for genomewide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9440–9445, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Papamarcaki and O. Tsolas, “Prothymosin α binds to histone H1 in vitro,” FEBS Letters, vol. 345, no. 1, pp. 71–75, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Karetsou, R. Sandaltzopoulos, M. Frangou-Lazaridis et al., “Prothymosin a modulates the interaction of histone H1 with chromatin,” Nucleic Acids Research, vol. 26, no. 13, pp. 3111–3118, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. W. H. Eschenfeldt and S. L. Berger, “The human prothymosin α gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 24, pp. 9404–9407, 1986. View at Google Scholar · View at Scopus
  22. F. J. Franco, C. Diaz, M. Barcia et al., “Synthesis and apparent secretion of prothymosin a by different subpopulations of calf and rat thymocytes,” Immunology, vol. 67, no. 2, pp. 263–268, 1989. View at Google Scholar · View at Scopus
  23. A. L. Goldstein, G. H. Cohen, G. B. Thurman, J. A. Hooper, and J. L. Rossio, “Regulation of immune balance by thymosin: potential role in the development of suppressor T-cells,” Advances in Experimental Medicine and Biology, vol. 66, pp. 221–228, 1976. View at Google Scholar · View at Scopus
  24. L. Romani, F. Bistoni, C. Montagnoli et al., “Thymosin a1: an endogenous regulator of inflammation, immunity, and tolerance,” Annals of the New York Academy of Sciences, vol. 1112, pp. 326–338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Haritos, O. Tsolas, and B. L. Horecker, “Distribution of prothymosin α in rat tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 5, pp. 1391–1393, 1984. View at Google Scholar · View at Scopus
  26. A. A. Haritos, G. J. Goodall, and B. L. Horecker, “Prothymosin α: isolation and properties of the major immunoreactive form of thymosin α1 in rat thymus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 4, pp. 1008–1011, 1984. View at Google Scholar · View at Scopus
  27. M. Freire, M. Rey-Mendez, J. Gomez-Marquez, and P. Arias, “Evidence for the synthesis of thymosin α1 by calf thymocytes and for the production of this peptide by natural processing,” Archives of Biochemistry and Biophysics, vol. 239, no. 2, pp. 480–485, 1985. View at Google Scholar · View at Scopus
  28. M. Lu, S. Menne, D. Yang, Y. Yu, and M. Roggendorf, “Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model,” Expert Opinion on Investigational Drugs, vol. 16, no. 6, pp. 787–801, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. Vela, G. C. Bowick, N. K. Herzog, and J. F. Aronson, “Exploring kinase inhibitors as therapies for human arenavirus infections,” Future Virology, vol. 3, no. 3, pp. 243–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Vela, G. C. Bowick, N. K. Herzog, and J. F. Aronson, “Genistein treatment of cells inhibits arenavirus infection,” Antiviral Research, vol. 77, no. 2, pp. 153–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Fennewald, E. P. Scott, L. Zhang et al., “Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections,” Journal of General Virology, vol. 88, no. 3, pp. 981–990, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. G. C. Bowick, S. M. Fennewald, L. Zhang et al., “Attenuated and lethal variants of pichinde virus induce differential patterns of NF-?B activation suggesting a potential target for novel therapeutics,” Viral Immunology, vol. 22, no. 6, pp. 457–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bozza, R. Gaziano, P. Bonifazi et al., “Thymosin a1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo,” International Immunology, vol. 19, no. 11, pp. 1261–1270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Peng, P. Zhang, X. Wang et al., “Signaling pathways leading to the activation of IKK and MAPK by thymosin a1,” Annals of the New York Academy of Sciences, vol. 1112, pp. 339–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Chen, M.-Y. He, and Y.-M. Li, “Treatment of patients with severe sepsis using Ulinastatin and Thymosin α1: a prospective, randomized, controlled pilot study,” Chinese Medical Journal, vol. 122, no. 8, pp. 883–888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhang, H. Chen, Y.-M. Li et al., “Thymosin a1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria,” Journal of Infectious Diseases, vol. 198, no. 5, pp. 723–730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Camerini, A. Ciancio, A. De Rosa, and M. Rizzetto, “Studies of therapy with thymosin α1 in combination with pegylated interferon α2a and ribavirin in nonresponder patients with chronic hepatitis C,” Annals of the New York Academy of Sciences, vol. 1112, pp. 368–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. W. Moody, “Thymosin α1 as a chemopreventive agent in lung and breast cancer,” Annals of the New York Academy of Sciences, vol. 1112, pp. 297–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Shuqun, W. Mengchao, C. Han et al., “Antiviral therapy using lamivudine and thymosin a1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection,” Hepato-Gastroenterology, vol. 53, no. 68, pp. 249–252, 2006. View at Google Scholar · View at Scopus
  40. D. Chadwick, J. Pido-Lopez, A. Pires et al., “A pilot study of the safety and efficacy of thymosin a1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy,” Clinical and Experimental Immunology, vol. 134, no. 3, pp. 477–481, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Karetsou, A. Kretsovali, C. Murphy, O. Tsolas, and T. Papamarcaki, “Prothymosin α interacts with the CREB-binding protein and potentiates transcription,” EMBO Reports, vol. 3, no. 4, pp. 361–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Djavani, O. R. Crasta, Y. Zhang et al., “Gene expression in primate liver during viral hemorrhagic fever,” Virology Journal, vol. 6, article 20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. M. Djavani, O. R. Crasta, J. C. Zapata et al., “Early blood profiles of virus infection in a monkey model for Lassa fever,” Journal of Virology, vol. 81, no. 15, pp. 7960–7973, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Martinez, C. Valmas, and C. F. Basler, “Ebola virus-like particle-induced activation of NF-κB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain,” Virology, vol. 364, no. 2, pp. 342–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Billecocq, M. Spiegel, P. Vialat et al., “NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription,” Journal of Virology, vol. 78, no. 18, pp. 9798–9806, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. G. Granja, M. L. Nogal, C. Hurtado et al., “The viral protein A238L inhibits TNF-a expression through a CBP/p300 transcriptional coactivators pathway,” Journal of Immunology, vol. 176, no. 1, pp. 451–462, 2006. View at Google Scholar · View at Scopus
  47. A. G. Granja, E. G. Sanchez, P. Sabina, M. Fresno, and Y. Revilla, “African swine fever virus blocks the host cell antiviral inflammatory response through a direct inhibition of PKC-θ-mediated p300 transactivation,” Journal of Virology, vol. 83, no. 2, pp. 969–980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. G. Granja, N. D. Perkins, and Y. Revilla, “A238L inhibits NF-ATc2, NF-κB, and c-Jun activation through a novel mechanism involving protein kinase C-θ-mediated up-regulation of the amino-terminal transactivation domain of p300,” Journal of Immunology, vol. 180, no. 4, pp. 2429–2442, 2008. View at Google Scholar · View at Scopus
  49. R. N. Silk, G. C. Bowick, C. C. Abrams, and L. K. Dixon, “African swine fever virus A238L inhibitor of NF-κB and of calcineurin phosphatase is imported actively into the nucleus and exported by a CRM1-mediated pathway,” Journal of General Virology, vol. 88, part 2, pp. 411–419, 2007. View at Publisher · View at Google Scholar · View at Scopus